TrialClinical pharmacology in drug development2022

Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects.

Jing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.